Nestlé to acquire Pfizer Nutrition in strategic move to enhance its position in global infant nutrition
April 23, 2012 | by Nestlé Suisse S.A.
Reading time: 1 minute
April 23, 2012, In a strategic move to enhance its position in global infant nutrition, Nestlé has agreed to acquire Pfizer Nutrition for USD 11.85 billion. The acquisition, which is subject to regulatory approval, will be accretive to the Nestlé model both for growth and margins as well as the group’s earnings per share in the full first year. Nestlé estimates the acquired business’ 2012 sales at USD 2.4 billion. Eighty five percent of Pfizer Nutrition’s sales are in emerging markets, many of them with large, fast-growing populations.
Infant nutrition is a high-value, science-led category. Pfizer Nutrition is a dynamic, high-quality infant nutrition business that complements Nestlé’s existing portfolio with strong brands in key segments and geographies. It will enhance our infant nutrition business, building on our growth- focused strategy, global presence and pioneering research and development. We will be able to combine well-known brands like S-26 Gold, SMA and Promil with our existing portfolio of trusted and successful brands such as Nan, Gerber, Lactogen, Nestogen and Cerelac infant cereal.
Contact
Nestlé Suisse S.A. Rue Entre-deux-Villes 10 1814 La Tour-de-Peilz Tel. 021 924 51 11 Fax 021 944 30 19
Editor's note: Image rights belong to the respective publisher.
Conclusion of this article: « Nestlé to acquire Pfizer Nutrition in strategic move to enhance its position in global infant nutrition »
Source: Nestlé Suisse S.A., Press release